Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta …
Background The clinical impact of different prophylactic anticoagulation regimens among
hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We …
hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We …
Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with …
Importance Hospitalized patients with COVID-19 are at risk for venous and arterial
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is …
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is …
Surviving Covid-19 with heparin?
Patients who are admitted to the hospital with coronavirus disease 2019 (Covid-19) are at
high risk for thrombosis, particularly venous thromboembolism (VTE). In a meta-analysis of …
high risk for thrombosis, particularly venous thromboembolism (VTE). In a meta-analysis of …
Clinical features of thrombosis and bleeding in COVID-19
Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
[HTML][HTML] Therapeutic versus prophylactic bemiparin in hospitalized patients with nonsevere COVID-19 pneumonia (BEMICOP study): an open-label, multicenter …
M Marcos-Jubilar, F Carmona-Torre… - Thrombosis and …, 2022 - thieme-connect.com
Thromboprophylaxis with low molecular weight heparin in hospitalized patients with COVID-
19 is mandatory, unless contraindicated. Given the links between inflammation and …
19 is mandatory, unless contraindicated. Given the links between inflammation and …
Anticoagulation in COVID-19 patients–An updated systematic review and meta-analysis
Background Thromboembolic events are common complications of COVID-19. Clinical study
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …
The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
Objective We aimed to perform a meta-analysis to summarize the overall evidence from
randomized controlled trials related to higher-intensity anticoagulation in hospitalized …
randomized controlled trials related to higher-intensity anticoagulation in hospitalized …
Central nervous system outcomes of COVID-19
The worldwide pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has infected an estimated 200 million people with over 4 million deaths …
(SARS-CoV-2) has infected an estimated 200 million people with over 4 million deaths …
Therapeutic implications of ongoing alveolar viral replication in COVID-19
In patients with moderate-to-severe COVID-19 pneumonia, an aberrant post-viral alveolitis
with excessive inflammatory responses and immunothrombosis underpins use of …
with excessive inflammatory responses and immunothrombosis underpins use of …